Remove tag
article thumbnail

A look back at the “Joint-efforts for pathogen genomics in public health surveillance” symposium

Sciensano

The “Joint-efforts for pathogen genomics in public health surveillance” symposium was successfully held on May 4, recording 160 registrations. During this event, Dr. Tim Dallman (University of Utrecht) lectured on specific case studies, advantages and challenges of routine genomic surveillance of gastrointestinal pathogens.

Genome 52
article thumbnail

How SARS-CoV-2 hijacks human cells to evade immune system

Scienmag

In short, the virus’ genome gets tagged with a […].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Epigenetics discovery could lead to new class of cancer drugs

Drug Discovery World

Epigenetics is still largely unexplored and referred to as the ‘dark matter’ of the genome. But, until now, scientists lacked an understanding of what the chemical tag does, despite many years of research.

article thumbnail

AI-designed protein awakens silenced genes, one by one

The Pharma Data

“The beauty of this approach is we can safely upregulate specific genes to affect cell activity without permanently changing the genome and cause unintended mistakes,” Levy said. PRC2 can be blocked with chemicals, but they are imprecise, affecting PRC2 function throughout the genome.

Protein 52
article thumbnail

IBM sells off large parts of Watson Health business

pharmaphorum

IBM said the sell-off is tagged as “a clear next step” as it focuses on its platform-based hybrid cloud and artificial intelligence strategy, but it’s no secret that Watson Health has failed to live up to its early promise.

Radiology 110
article thumbnail

Targeting a human protein may stop Ebola virus in its tracks

The Pharma Data

Polymerase is a viral protein that directs how Ebola virus replicates its genome as it infects new hosts. Back in 2018, researchers tested a broad-spectrum antiviral candidate called remdesivir/VEKLURY, which acts as a nucleotide decoy to get incorporated into the viral RNA genome and stop viral polymerase.

Protein 52
article thumbnail

WHO update on Omicron

The Pharma Data

1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). WHO’s TAG-VE will continue to monitor and evaluate the data as it becomes available and assess how mutations in Omicron alter the behaviour of the virus. Recommended actions for countries.